WCOE: Pace of FDA Drug Approvals, Redesigning Insurance Exchanges, Shared Decision Making, and Thoughts on Data Collection
What Caught Our Eye (WCOE) Each week, we recap the cancer policy articles, studies, and stories that caught our attention. |
Too Fast, or Too Slow? Public disagrees over pace of #FDA's new drug approvals https://t.co/gnvqJq56AH via @RAPSorg
— ResearchAmerica (@ResearchAmerica) February 25, 2015
Everything I know about a good death I learned from my cat https://t.co/KeC5qEcynk
— Shelley Fuld Nasso (@sfuldnasso) February 25, 2015
A Faster Way to Try Many Drugs on Many Cancers https://t.co/EFms6hYq3d
— NCCS – National Coalition for Cancer Survivorship (@CancerAdvocacy) February 26, 2015
When the System Fails https://t.co/prtyMzyKwO via @nytopinionator The cancer care and death planning of a pt w/ melanoma
— NCCS – National Coalition for Cancer Survivorship (@CancerAdvocacy) February 25, 2015
My interview with @NEJM about https://t.co/EeFN5kID4z 3.0 on redesigning #healthcare insurance exchanges https://t.co/fcfhxCUqU1 #healthpolicy
— Peter Ubel (@peterubel) February 24, 2015
When helping #cancer patients with decision making, should we pay more attention to family members? https://t.co/BAmwTA5ww5 @JournalCancer
— Yousuf Zafar, MD MHS (@yzafar) February 23, 2015
Heart Health After Cancer: A Growing Concern https://t.co/NIdzFRiJmh via @forbes @ElaineSchattner
— NCCS – National Coalition for Cancer Survivorship (@CancerAdvocacy) February 23, 2015
Do patients fail therapies, or do the therapies fail them? https://t.co/VNomph239n
— Shelley Fuld Nasso (@sfuldnasso) February 22, 2015